Log in
Enquire now

List of Inbiomotion patents

List of Inbiomotion patents
List of Cellerant Therapeutics patents
List of Juno Therapeutics patents
List of Skyhawk Therapeutics patents
List of Chicago/Booth Graduates Who Have Founded Companies
List of awards received by Sadio Mané
Patents where
Current Assignee
Name
is
InbiomotionInbiomotion
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 11041213 Method for the diagnosis, prognosis and treatment of prostate cancer metastasis

Patent 11041213 was granted and assigned to Inbiomotion on June, 2021 by the United States Patent and Trademark Office.

Inbiomotion
Inbiomotion
Inbiomotion
Inbiomotion
United States Patent and Trademark Office
United States Patent and Trademark Office
11041213
June 22, 2021
‌
US Patent 10119171 Method for the diagnosis, prognosis and treatment of prostate cancer metastasis

Patent 10119171 was granted and assigned to Inbiomotion on November, 2018 by the United States Patent and Trademark Office.

Inbiomotion
Inbiomotion
Inbiomotion
Inbiomotion
United States Patent and Trademark Office
United States Patent and Trademark Office
10119171
November 6, 2018
‌
US Patent 11041861 Method for the diagnosis, prognosis and treatment of prostate cancer metastasis

Patent 11041861 was granted and assigned to Inbiomotion on June, 2021 by the United States Patent and Trademark Office.

Inbiomotion
Inbiomotion
Inbiomotion
Inbiomotion
United States Patent and Trademark Office
United States Patent and Trademark Office
11041861
June 22, 2021
‌
US Patent 10114022 Method for the diagnosis, prognosis and treatment of prostate cancer metastasis

Patent 10114022 was granted and assigned to Inbiomotion on October, 2018 by the United States Patent and Trademark Office.

Inbiomotion
Inbiomotion
Inbiomotion
Inbiomotion
United States Patent and Trademark Office
United States Patent and Trademark Office
10114022
October 30, 2018
‌
US Patent 11654153 Therapeutic treatment of breast cancer based on c-MAF status

Patent 11654153 was granted and assigned to Inbiomotion on May, 2023 by the United States Patent and Trademark Office.

Inbiomotion
Inbiomotion
Inbiomotion
Inbiomotion
United States Patent and Trademark Office
United States Patent and Trademark Office
11654153
May 23, 2023
‌
US Patent 11596642 Therapeutic treatment of breast cancer based on c-MAF status

Patent 11596642 was granted and assigned to Inbiomotion on March, 2023 by the United States Patent and Trademark Office.

Inbiomotion
Inbiomotion
Inbiomotion
Inbiomotion
United States Patent and Trademark Office
United States Patent and Trademark Office
11596642
March 7, 2023
‌
US Patent 10793642 Binding members for human c-MAF

Patent 10793642 was granted and assigned to Inbiomotion on October, 2020 by the United States Patent and Trademark Office.

Inbiomotion
Inbiomotion
Inbiomotion
Inbiomotion
United States Patent and Trademark Office
United States Patent and Trademark Office
10793642
October 6, 2020
‌
US Patent 11840740 Method for the diagnosis, prognosis and treatment of prostate cancer metastasis

Patent 11840740 was granted and assigned to Inbiomotion on December, 2023 by the United States Patent and Trademark Office.

Inbiomotion
Inbiomotion
Inbiomotion
Inbiomotion
United States Patent and Trademark Office
United States Patent and Trademark Office
11840740
December 12, 2023
‌
US Patent 11892453 Method for the diagnosis, prognosis and treatment of prostate cancer metastasis

Patent 11892453 was granted and assigned to Inbiomotion on February, 2024 by the United States Patent and Trademark Office.

Inbiomotion
Inbiomotion
Inbiomotion
Inbiomotion
United States Patent and Trademark Office
United States Patent and Trademark Office
11892453
February 6, 2024
9 results
0 selected
9 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us